Advertisement
Advertisement
ACRS
Aclaris Therapeutics, Inc.
3.90
USDSponsored
+0.29
+8.03%
Nov 06, 15:59 UTC -5
Closed
After-Market
3.90
0.00
-0.13%
Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. Financial Snapshot
| Market Cap | 603.67M |
| Beta | 0.96 |
| Earnings Per Share (EPS) | -0.58 |
| Price-to-Book (P/B) Ratio | 4.26 |
| Operating Margin | -921.50% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -61.65% |
| Current Ratio | 3.46% |
| Free Cash Flow | -38.07M |
